Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
You can no more keep a tomato on a vine than prevent a child from growing up. That growth, those transitions, and the milestones are all worth marking. In that spirit, I hope you’ll take a a minute to see what inspires our team of “glow getters” celebrating in our fields this harvest and witness some of the Heart+Soil embedded in our mission, our culture and our promise to the world.
– Shirley Cohen, CEO
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
Interested in speaking directly with a member of our team?
Click below to get in touch.